<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="./PMC5923199/results/search/disease/results.xml">
  <result pre="crucial for induction of pruritus, but not inflammation, in contact" exact="hypersensitivity" post="Takamori Ayako 1 2 http://orcid.org/0000-0002-2797-6420 Nambu Aya 1 Sato"/>
  <result pre="was reported to be increased in specimens from patients with" exact="atopic dermatitis," post="and IL-31-transgenic mice develop atopic dermatitis-like skin inflammation, which"/>
  <result pre="dermatitis-like skin inflammation, which is involved in the pathogenesis of" exact="atopic dermatitis." post="However, the role of IL-31 in development of contact"/>
  <result pre="However, the role of IL-31 in development of contact dermatitis/contact" exact="hypersensitivity" post="(CHS), which is mediated by hapten-specific T cells, including"/>
  <result pre="involved in the pathogenesis of such allergic disorders as rhinitis," exact="asthma" post="and dermatitis 5 . Indeed, increased levels of IL-31"/>
  <result pre="the pathogenesis of such allergic disorders as rhinitis, asthma and" exact="dermatitis" post="5 . Indeed, increased levels of IL-31 were observed"/>
  <result pre="of IL-31 were observed in nasal secretions of patients with" exact="allergic rhinitis" post="11 . IL-31 levels in sera or PBMCs were"/>
  <result pre="IL-31 were observed in nasal secretions of patients with allergic" exact="rhinitis" post="11 . IL-31 levels in sera or PBMCs were"/>
  <result pre="in sera or PBMCs were significantly increased in patients with" exact="asthma" post="12 , and IL-31 can activate human bronchial epithelial"/>
  <result pre="specimens as plasma, sera and/or cutaneous biopsies from patients with" exact="atopic dermatitis" post="14, 15 or contact dermatitis 16 . In particular,"/>
  <result pre="as plasma, sera and/or cutaneous biopsies from patients with atopic" exact="dermatitis" post="14, 15 or contact dermatitis 16 . In particular,"/>
  <result pre="cutaneous biopsies from patients with atopic dermatitis 14, 15 or" exact="contact dermatitis" post="16 . In particular, IL-31 was implicated in itching"/>
  <result pre="biopsies from patients with atopic dermatitis 14, 15 or contact" exact="dermatitis" post="16 . In particular, IL-31 was implicated in itching"/>
  <result pre="or specific for lymphocytes, spontaneously develop skin inflammation resembling human" exact="atopic dermatitis" post="and show severe scratching behavior accompanied by exfoliation of"/>
  <result pre="specific for lymphocytes, spontaneously develop skin inflammation resembling human atopic" exact="dermatitis" post="and show severe scratching behavior accompanied by exfoliation of"/>
  <result pre="in inflamed lesions of skin from mice that developed allergic" exact="dermatitis" post="resembling human atopic dermatitis 17 . Administration of anti-IL-31"/>
  <result pre="of skin from mice that developed allergic dermatitis resembling human" exact="atopic dermatitis" post="17 . Administration of anti-IL-31 or anti-IL-31RA neutralizing Ab"/>
  <result pre="skin from mice that developed allergic dermatitis resembling human atopic" exact="dermatitis" post="17 . Administration of anti-IL-31 or anti-IL-31RA neutralizing Ab"/>
  <result pre="in that mouse model 18, 19 or in patients with" exact="atopic dermatitis" post="20 . On the other hand, the role of"/>
  <result pre="that mouse model 18, 19 or in patients with atopic" exact="dermatitis" post="20 . On the other hand, the role of"/>
  <result pre="the role of IL-31 in the development of contact dermatitis/contact" exact="hypersensitivity" post="(CHS) is not well understood. CHS is a T-cell-mediated"/>
  <result pre="IL-31 production in IL-31 Tg mice resulted in development of" exact="dermatitis" post="due to enhancement of type–2 immune responses 1 ."/>
  <result pre="the lack of IL-31R (IL-31RA and OSMR), resulting in OSM-mediated" exact="suppression" post="of type–2 immune responses 13 . Therefore, to investigate"/>
  <result pre="the pathogenesis of type–2 cytokine-associated allergic disorders such as rhinitis," exact="asthma" post="and dermatitis 5 . In support of that notion,"/>
  <result pre="of type–2 cytokine-associated allergic disorders such as rhinitis, asthma and" exact="dermatitis" post="5 . In support of that notion, the levels"/>
  <result pre="notion, the levels of IL-31 were increased in patients with" exact="allergic rhinitis" post="11 , asthma 12 and atopic dermatitis 14, 15"/>
  <result pre="the levels of IL-31 were increased in patients with allergic" exact="rhinitis" post="11 , asthma 12 and atopic dermatitis 14, 15"/>
  <result pre="IL-31 were increased in patients with allergic rhinitis 11 ," exact="asthma" post="12 and atopic dermatitis 14, 15 . DNFB- and/or"/>
  <result pre="in patients with allergic rhinitis 11 , asthma 12 and" exact="atopic dermatitis" post="14, 15 . DNFB- and/or FITC-induced CHS was attenuated"/>
  <result pre="patients with allergic rhinitis 11 , asthma 12 and atopic" exact="dermatitis" post="14, 15 . DNFB- and/or FITC-induced CHS was attenuated"/>
  <result pre="the levels of IL-31 were also elevated in patients with" exact="contact dermatitis" post="16 . These observations suggest that IL-31 may be"/>
  <result pre="levels of IL-31 were also elevated in patients with contact" exact="dermatitis" post="16 . These observations suggest that IL-31 may be"/>
  <result pre="performed using FlowJo software (Tree Star Inc.). Induction of contact" exact="hypersensitivity" post="(CHS) CHS was induced with FITC and DNFB as"/>
  <result pre="Interleukin 31, a cytokine produced by activated T cells, induces" exact="dermatitis" post="in mice Nat Immunol 2004 5 752 760 10.1038/ni1084"/>
  <result pre="than IL-17 and BAFF are potential indicators in patients with" exact="allergic asthma" post="Allergy 2008 63 327 332 10.1111/j.1398-9995.2007.01566.x 18053009 13. Bilsborough"/>
  <result pre="IL-17 and BAFF are potential indicators in patients with allergic" exact="asthma" post="Allergy 2008 63 327 332 10.1111/j.1398-9995.2007.01566.x 18053009 13. Bilsborough"/>
  <result pre="et al. Correlation of IL-31 serum levels with severity of" exact="atopic dermatitis" post="J Allergy Clin Immunol 2008 122 421 423 10.1016/j.jaci.2008.05.047"/>
  <result pre="al. Correlation of IL-31 serum levels with severity of atopic" exact="dermatitis" post="J Allergy Clin Immunol 2008 122 421 423 10.1016/j.jaci.2008.05.047"/>
  <result pre="of IL-31 correlate with IL-4 and IL-13 in atopic and" exact="allergic contact dermatitis" post="J Allergy Clin Immunol 2006 118 930 937 10.1016/j.jaci.2006.07.015"/>
  <result pre="IL-31 correlate with IL-4 and IL-13 in atopic and allergic" exact="contact dermatitis" post="J Allergy Clin Immunol 2006 118 930 937 10.1016/j.jaci.2006.07.015"/>
  <result pre="correlate with IL-4 and IL-13 in atopic and allergic contact" exact="dermatitis" post="J Allergy Clin Immunol 2006 118 930 937 10.1016/j.jaci.2006.07.015"/>
  <result pre="al. Expression of IL-31 gene transcripts in NC/Nga mice with" exact="atopic dermatitis" post="Eur J Pharmacol 2005 516 180 181 10.1016/j.ejphar.2005.04.040 15925362"/>
  <result pre="Expression of IL-31 gene transcripts in NC/Nga mice with atopic" exact="dermatitis" post="Eur J Pharmacol 2005 516 180 181 10.1016/j.ejphar.2005.04.040 15925362"/>
  <result pre="Anti-interleukin-31-antibodies ameliorate scratching behaviour in NC/Nga mice: a model of" exact="atopic dermatitis" post="Exp Dermatol 2009 18 35 43 10.1111/j.1600-0625.2008.00766.x 19054054 19."/>
  <result pre="ameliorate scratching behaviour in NC/Nga mice: a model of atopic" exact="dermatitis" post="Exp Dermatol 2009 18 35 43 10.1111/j.1600-0625.2008.00766.x 19054054 19."/>
  <result pre="to be a potential therapeutic option for treating itch and" exact="dermatitis" post="in mice Br J Pharmacol 2014 171 5049 5058"/>
  <result pre="BZ Gaspari AA Early immune events in the induction of" exact="allergic contact dermatitis" post="Nat Rev Immunol 2012 12 114 124 10.1038/nri3150 22240625"/>
  <result pre="Gaspari AA Early immune events in the induction of allergic" exact="contact dermatitis" post="Nat Rev Immunol 2012 12 114 124 10.1038/nri3150 22240625"/>
  <result pre="AA Early immune events in the induction of allergic contact" exact="dermatitis" post="Nat Rev Immunol 2012 12 114 124 10.1038/nri3150 22240625"/>
  <result pre="Oboki K Ohno T Saito H Nakae S Th17 and" exact="allergy" post="Allergol Int 2008 57 121 134 10.2332/allergolint.R-07-160 18427165 23."/>
  <result pre="487 10.1084/jem.20061791 17353366 24. Weigmann B et al. Diminished contact" exact="hypersensitivity" post="response in IL-4 deficient mice at a late phase"/>
  <result pre="Jugert F Krieg T Merk H Hunzelmann N Inhibition of" exact="allergic contact dermatitis" post="to DNCB but not to oxazolone in interleukin-4-deficient mice"/>
  <result pre="F Krieg T Merk H Hunzelmann N Inhibition of allergic" exact="contact dermatitis" post="to DNCB but not to oxazolone in interleukin-4-deficient mice"/>
  <result pre="Krieg T Merk H Hunzelmann N Inhibition of allergic contact" exact="dermatitis" post="to DNCB but not to oxazolone in interleukin-4-deficient mice"/>
  <result pre="of transcription 6 is essential in the induction of contact" exact="hypersensitivity" post="J Exp Med 2000 191 995 1004 10.1084/jem.191.6.995 10727461"/>
 </snippets>
</snippetsTree>
